Hello everyone. Here is a link to the slides that Brandon presented to members of this group: an overview of the project: * https://nciphub.org/groups/eedapstudies/wiki/HighthroughputTruthingYear2/File:20181130-HTToverviewToCollabs.pdf Roberto Salgado has invited Brandon to present to the www.tilsinbreastcancer.org working group face-to-face meeting attached to the San Antonio Breast Cancer. The presentation will largely be the overview linked above. *Thursday, December 6, 2018, 7am-9am (EST). Ashish Sharma will give an Overview of !QuIP/caMicroscope and the TCIA pathology capabilities. We will harness these tools in the HTT project so humans and algorithms can annotate the images via web-based apps to prepare our studies. * Monday, December 10, 2018, 11am-12pm (EST) * !WebEx info below abstract. Abstract: An overview of !QuIP/caMicroscope and the TCIA pathology capabilities. This includes image management, visualization, cloud computing, human/machine annotation and markup and the dissemination of this data. We can also discuss the scope, scale and capabilities of our various digital pathology research activities, including our collaboration with the SEER program. Join !Webex meeting * https://fda1.webex.com/fda1/j.php?MTID=mbee218a10bec84c095027f6958df8a34 Meeting number (access code): 901 145 661 Meeting password: mUHY7am2 Join by phone +1-210-795-0506 US Toll +1-877-465-7975 US Toll Free Global call-in numbers * https://fda1.webex.com/fda1/globalcallin.php?serviceType=MC&ED=10036292&tollFree=1 Toll-free calling restrictions * https://e-meetings.verizonbusiness.com/global/pdf/Verizon_Audio_Conferencing_Global_Access_Information_August2017.pdf Can't join the meeting? * https://collaborationhelp.cisco.com/article/WBX000029055 IMPORTANT NOTICE: Please note that this Webex service allows audio and other information sent during the session to be recorded, which may be discoverable in a legal matter. By joining this session, you automatically consent to such recordings. If you do not consent to being recorded, discuss your concerns with the host or do not join the session.